M&A Deal Summary

Pernix Therapeutics Holdings Acquires Cypress Pharmaceuticals

On January 2, 2012, Pernix Therapeutics Holdings acquired medical products company Cypress Pharmaceuticals

Acquisition Highlights
  • This is Pernix Therapeutics Holdings’ 1st transaction in the Medical Products sector.
  • This is Pernix Therapeutics Holdings’ 1st transaction in the United States.
  • This is Pernix Therapeutics Holdings’ 1st transaction in Mississippi.

M&A Deal Summary
Date 2012-01-02
Target Cypress Pharmaceuticals
Sector Medical Products
Buyer(s) Pernix Therapeutics Holdings
Deal Type Add-on Acquisition

Target

Cypress Pharmaceuticals

Madison, Mississippi, United States
Cypress Pharmaceuticals manufactures, markets and/or distributes more than 231 drugs in the United States.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Pernix Therapeutics Holdings

Morristown, New Jersey, United States
Category Company
Founded 1996
Sector Life Science
Employees155
Revenue 176M USD (2015)
DESCRIPTION

Pernix Therapeutics Holdings, Inc. is a pharmaceutical company developing branded and generic pediatric products. Pernix Therapeutics was founded in 1996 and is based in Morristown, New Jersey.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (Mississippi) 1 of 1
Country (United States) 1 of 2
Year (2012) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-11 Somaxon Pharmaceuticals

Solana Beach, California, United States

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focuses on psychiatric and neurological conditions.

Buy $25M
Mergr

Product

Company

Legal